Chyanne Fickes

Markets. Italy is very concerning. Don’t know who will be running the show. It puts the Euro in a new light. This election has really put Italy back in the forefront. The fourth largest debtor in the world. The impact on the economy will not be as much as the payroll tax will be. Italy could be the trigger for a correction, or it could be upcoming earnings for first quarter. Focusing on technology and healthcare stocks but keeping cash on the side.

Trading at a relatively high valuation but a nice dividend. Great stock. Pharma and consumer. She would be willing to buy it now. 3.2% dividend.

Valuation getting a little stretched. 3.7% yield. BCE is not a bad idea either and has their stated dividend policy.

Has heard the BB-10 is a really, really good product. Sales have been sharply lower than the company’s estimates. That pushes out the profitability another year. Not a bad idea to average down because it will trade in this range for some time.

Excellent stock and excellent products. Just came out with new ones yesterday. Continued sustainability in the average selling price of the handsets. 4.5 times earnings. Handsets are only 16 percent of market so lots of growth.

Dividend stocks on Canada including banks are a little over stretched. Good yield, but she would take a few profits and put it in the US banks.

She sold ABv. But ABT-N has a very good basic business. Doesn’t understand why they don’t pay more dividend (1.6%) and thinks they may increase it soon.

Had trials over the last while. Keep buying back stock and it keeps going down. Might be selling interest in Verizon. Wait until new regulation in Europe re telecoms are published.

Has plateaued. Is very fully valued at 30 times earnings.

US plays are cheaper. Have done very well in the last year. Some of the risk has been taken out. 8.5 times earnings, just under book.

(Top Pick Jul 6/12, Up 13.17%) A problem with them not hitting a settlement. Next product in a little while. 28 times earnings. Growth is so high that it will be less than 10. Second largest generic drug company in the world. TEVA has a whole lot of warts on it at this point.

They have the largest exposure to Europe in terms of Europe but thinks they have already seen the worst. Their products are very needed.

(Top Pick Jul 6/12, Down 24.44% Total Return) Incredible value. It is so cheap. But earnings could be problematic over the next couple of quarters. She has been selling at higher prices.

(Top Pick Jul 6/12, Up 10.95% Total Return)

Markets. Thinks that it will get down to the wire and it will be a gradual thing come January. The chances of them letting it go, it would be ridiculous. If the US goes into a recession this time, Canada will be far greater than last time. It is unlikely that scenario would play out. She prefers a lot of US stocks because they look relatively attractive. Likes the lack of exposure to commodities. In Canada, likes Energy, dislikes Materials, mining. Likes Financial but it is fully values and that is the Canadian market.